socalTECH

MARCH 15, 2012

San Diego-based Avalon Ventures , one of the venture capital investors in social gaming phenomenon Zynga , may be set to cash in on its shares of the newly public gaming firm, after Zynga said this week that it is planning a $400M, secondary offering of its stock.

Avalon 150

Avalon Southern California SoCal San Diego 150

socalTECH

JULY 1, 2011

According to Zynga, it is looking to raise up to $1 billion on the public markets. Among the investors who may benefit from a successful IPO are La Jolla-based Avalon Ventures , run by Kevin Kinsella, Stephen Tomlin, Richard Levandov, Brady Bohrmann, Doug Downs and Jay Lichter, which before the IPO owned 6.1 percent of Zynga.

Avalon 140

Avalon Southern California Class Marketing 140

socalTECH

FEBRUARY 5, 2014

The company is offering up 3,529,411 shares of its stock, and plans to trade on the NASDAQ Global Market as INGN. Inogen is venture backed by Novo AS, Versant Ventures, Arborteum Ventures, Avalon Ventures, and Accuitive Medical Ventures. inogen merger acquisition exist medical equipment lifescience ingn' READ MORE>>.

Avalon 214

Avalon Pricing Acquisition Marketing 214

socalTECH

DECEMBER 2, 2013

Goleta-based medical equipment manufacturer Inogen filed for an IPO over the weekend, saying that it plans to list on the NASDAQ Global Market under the symbol INGN. Inogen is venture backed by Novo A/S, Versant Ventures, Arboretum Ventures, Avalon Ventures, AMV Partners, and others. The company''s IPO is being underwritten by J.P.

Avalon 153

Avalon Acquisition Marketing Develop 153

socalTECH

JULY 14, 2014

San Diego-based Otonomy , the biopharmaceuticals firm which is developing treatment of diseases and disorders of the ear, has filed for an IPO, saying in a filing that it is looking to raised $86.25M in an offering on the NASDAQ Global Market. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit'

Avalon 147

Avalon San Diego Acquisition Marketing 147

socalTECH

JULY 16, 2013

In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. The fund has not yet announced local investments, but has been actively talking to companies fitting its investment profile.

Capital 174

Capital Southern California Avalon SoCalTech 174

socalTECH

AUGUST 4, 2014

Otonomy has applied to list on the NASDAQ Global Market as OTIC. The company is venture backed by Avalon Ventures, OrbiMed, Novo AS, TPG Biotech, Domain Associates, Rivervest Venture Partners, as well as others. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing' and $16.00

Pricing 147

Pricing Avalon San Diego Acquisition 147